A. Delforge

发表

A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment.

M. Najar, L. Lagneaux, D. Bron, 2011, Stem cells and development.

Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood.

P. Martiat, D. Bron, C. De Bruyn, 2005, Stem cells and development.

The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces apoptosis, downregulates the CXCR4 chemokine receptor and impairs migration of chronic lymphocytic leukemia cells Running title: SAHA decreases CXCR4 and CLL cell migration

L. Lagneaux, D. Bron, B. Stamatopoulos, 2009 .

Production of human monoclonal IgG antibodies reacting with cytomegalovirus (CMV).

A. Burny, E. Bosmans, R. Snoeck, 1990, Journal of immunological methods.

Excessive production of transforming growth factor-beta by bone marrow stromal cells in B-cell chronic lymphocytic leukemia inhibits growth of hematopoietic precursors and interleukin-6 production.

L. Lagneaux, D. Bron, A. Delforge, 1993, Blood.

Autologous cord blood use: Clinical and scientific aspects

D. Latinne, A. Ferrant, Y. Benoît, 2011 .

Ultrasonic low-energy treatment: a novel approach to induce apoptosis in human leukemic cells.

L. Lagneaux, D. Bron, A. Delforge, 2002, Experimental hematology.

Mesenchymal Stem Cells Derived from CD133‐Positive Cells in Mobilized Peripheral Blood and Cord Blood: Proliferation, Oct4 Expression, and Plasticity

L. Lagneaux, D. Bron, N. Meuleman, 2005, Stem cells.

Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL‐3), IL‐6, granulocyte‐macrophage colony stimulating factor (GM‐CSF) and stem cell factor (SCF) in serum‐supplemented and serum‐free medium

D. Bron, D. Hemptinne, D. de Hemptinne, 1994, Stem cells.

Adhesion to bone marrow stroma inhibits apoptosis of chronic lymphocytic leukemia cells.

L. Lagneaux, D. Bron, M. Bernier, 1999, Leukemia & lymphoma.

Influence of recombinant alpha and gamma interferons on the in vitro proliferation of myeloid and leukemic progenitors

L. Lagneaux, L. Debusscher, D. Bron, 1990, European journal of haematology.

Ex vivo expansion of neutrophil precursor cells from fresh and cryopreserved cord blood cells.

D. Bron, M. Bernier, C. De Bruyn, 2003, Cytotherapy.

Ex vivo expansion of neutrophil precursor cells from mobilized peripheral blood cells: similar results in cancer patients and normal donors.

P. Martiat, D. Bron, C. De Bruyn, 2005, Cytotherapy.

Sensitivity of normal human bone marrow myeloid progenitor cells to anthracycline, cisplatin, anthracene and flavone acetic acid derivatives, and its relevance for the prediction of human plasma concentrations of anticancer drugs.

M. Rozencweig, D. Bron, P. Dodion, 1987, European journal of cancer & clinical oncology.

Gene expression pattern of functional neuronal cells derived from human bone marrow mesenchymal stromal cells

P. Martiat, L. Lagneaux, D. Bron, 2008, BMC Genomics.

Isolation of BM mesenchymal stem cells by plastic adhesion or negative selection: phenotype, proliferation kinetics and differentiation potential.

L. Lagneaux, D. Bron, T. Tondreau, 2004, Cytotherapy.

Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study.

P. Martiat, I. Ahmad, L. Lagneaux, 2009, Stem cells and development.

Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation.

L. Lagneaux, D. Bron, T. Tondreau, 2004, Differentiation; research in biological diversity.

TGF-beta activity and expression of its receptors in B-cell chronic lymphocytic leukemia.

L. Lagneaux, D. Bron, M. Bernier, 1998, Leukemia & lymphoma.

Heterogenous response of B lymphocytes to transforming growth factor‐beta in B‐cell chronic lymphocytic leukaemia: correlation with the expression of TGF‐β receptors

L. Lagneaux, D. Bron, M. Bernier, 1997, British journal of haematology.

Comparative analysis of cytokines released by bone marrow stromal cells from normal donors and B-cell chronic lymphocytic leukemic patients.

E. Bosmans, L. Lagneaux, D. Bron, 1995, Leukemia & lymphoma.

Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study

P. Martiat, P. Lewalle, D. Bron, 2003, Bone Marrow Transplantation.

Human cytomegalovirus increases constitutive production of interleukin-6 and leukemia inhibitory factor by bone marrow stromal cells.

E. De Clercq, E. Bosmans, J. Moreau, 1996, Blood.

ANTI-COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIBODY ( CALLA ) ( J 5 ) REACTIVITY BY SMALL CELL LUNG CANCER

L. Lagneaux, A. Delforge, P. Stryckmans, 2005 .

Granulocyte‐macrophage progenitor cell preservation at 4°C

E. Ronge-Collard, A. Delforge, P. Stryckmans, 1983, British journal of haematology.

Imbalance in production of cytokines by bone marrow stromal cells following cytomegalovirus infection.

E. Bosmans, D. Schols, R. Snoeck, 1996, The Journal of infectious diseases.

In vitro chemosensitivity testing of flavone acetic acid (LM975; NSC 347512) and its diethylaminoethyl ester derivative (LM985; NSC 293015).

P. Dodion, W. Schroyens, A. Delforge, 1987, European journal of cancer & clinical oncology.

Early induction of apoptosis in B‐chronic lymphocytic leukaemia cells by hydroxychloroquine: activation of caspase‐3 and no protection by survival factors

L. Lagneaux, D. Bron, M. Bernier, 2001, British journal of haematology.

Chronic Lymphocytic Leukemic B Cells But Not Normal B Cells Are Rescued From Apoptosis by Contact With Normal Bone Marrow Stromal Cells

L. Lagneaux, D. Bron, A. Delforge, 1998 .

Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitro

J. Balzarini, E. Clercq, R. Snoeck, 1990, European Journal of Clinical Microbiology and Infectious Diseases.

Analysis of interferon-inducible genes in cells of chronic myeloid leukemia patients responsive or resistant to an interferon-alpha treatment.

G. Huez, Marc G. Wathelet, J. Content, 1990, Blood.

In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues.

P. Martiat, L. Lagneaux, D. Bron, 2009, Cytotherapy.

A case of chronic aneosinocytosis

R. Amson, A. Telerman, A. Delforge, 1982, American journal of hematology.

Treatment of brain giomas with high dose of CCNU and autologous bone marrow transplantation.

J. Hildebrand, A. Delforge, P. Stryckmans, 1980, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Quantitation of differential sensitivity of normal marrow myeloid progenitor cells to anthracene derivatives

M. Rozencweig, D. Bron, P. Dodion, 2004, Investigational New Drugs.

Ex vivo expansion of CD34 + CD38- cord blood cells.

D. Bron, M. Bernier, D. de Hemptinne, 1997, Journal of hematotherapy.

Increased levels of myeloid progenitor cells in the blood of patients with metastatic invasion of the marrow.

E. Ronge-Collard, A. Delforge, P. Stryckmans, 2009, Scandinavian journal of haematology.

Effect of 4-hydroperoxycyclophosphamide on leukemic and normal human myeloid progenitor cells.

L. Debusscher, E. Ronge-Collard, A. Delforge, 1985, Leukemia research.

Effect of 2 anti-arrhythmic drugs aprindine and moxaprindine on the replication capacity of murine and human haemopoietic cells.

S. Suciu, E. Ronge-Collard, A. Delforge, 2009, Scandinavian journal of haematology.

Human monoclonal antibodies: new approaches and perspectives in cancer.

D. Bron, A. Delforge, P. Stryckmans, 1985, European journal of cancer & clinical oncology.

Circadian and seasonal variations of hematopoiesis in cord blood.

V. Deneys, G. Fillet, C. Vermylen, 1998, Bone marrow transplantation.

A Calcium‐Dependent Protein Activator of Guanosine 3′:5′‐Monophosphate Phosphodiesterase in Bovine and Rat Pancreas

A. Vandermeers, M. Vandermeers-piret, J. Rathé, 1977 .

Measurement of Soluble Interleukin 2 Receptor in Sera of Adult Patients with Hematological or Solid Malignancies.

E. Bosmans, J. Raus, D. Bron, 1991, Leukemia & lymphoma.

Scientific basis and criticism of current therapy of acute leukemia.

S. Suciu, L. Debusscher, D. Bron, 1982, Blood cells.

Circadian and circannual variations in cord blood hematopoietic cell composition

V. Deneys, D. Bron, L. Seidel, 2015, Haematologica.

Comparison of the coexpression of cd38, cd33 and hla‐dr antigens on cd34+ purified cells from human cord blood and bone marrow

D. Bron, M. Bernier, D. Hemptinne, 1995, Stem cells.

Lactoferrin: Its Role as a Regulator of Human Granulopoiesis? a

J. Prieels, E. Ronge-Collard, A. Delforge, 1985, Annals of the New York Academy of Sciences.

Myeloid and lymphoid recovery following allogeneic bone marrow transplantation: a comparative study between related, unrelated bone marrow and allogeneic peripheral stem cell transplantation.

D. Bron, M. Bernier, M. Maerevoet, 1998, Leukemia & lymphoma.

Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.

P. Martiat, L. Willems, A. Kentos, 2006, Experimental hematology.

Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells.

L. Lagneaux, D. Bron, D Bron, 1998, Blood.

Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2 [ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumors.

R. Stahel, J. Sculier, J. Klastersky, 1989, European journal of cancer & clinical oncology.

Growth factors and DLI in adult haploidentical transplant: a three-step pilot study towards patient and disease status adjusted management.

P. Martiat, L. Lagneaux, K. Theunissen, 2004, Blood cells, molecules & diseases.

Human marrow mesenchymal stem cell culture: serum‐free medium allows better expansion than classical α‐MEM medium

L. Lagneaux, D. Bron, Nathalie Meuleman, 2006, European journal of haematology.

Characterization of CD34+ subsets derived from bone marrow, umbilical cord blood and mobilized peripheral blood after stem cell factor and interleukin 3 stimulation

L. Lagneaux, D. Bron, A. Delforge, 2000, Bone Marrow Transplantation.

Disciplinary Approach to Understanding Cytomegalovirus Disease

E. Clercq, R. Snoeck, L. Lagneaux, 1993 .

Access to human tissues for research and product development

Sigrid Sterckx, Michiel Verlinden, Kris Dierickx, 2015, EMBO reports.

The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis, down-regulates the CXCR4 chemokine receptor and impairs migration of chronic lymphocytic leukemia cells

L. Lagneaux, D. Bron, B. Stamatopoulos, 2010, Haematologica.

Hydroxychloroquine-induced Apoptosis of Chronic Lymphocytic Leukemia Involves Activation of Caspase-3 and Modulation of Bcl-2/bax/ratio

L. Lagneaux, D. Bron, M. Bernier, 2002, Leukemia & lymphoma.

Modulation of the growth of hematopoietic human stem cells by growth factors: comparison of umbilical cord blood with bone marrow.

M. Degueldre, D. Bron, A. Delforge, 1993, Journal of Hematotherapy.

Perturbation of cytokine production by bone marrow stromal cells after cytomegalovirus infection

E. Clercq, R. Snoeck, L. Lagneaux, 1993 .

Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells.

R. Snoeck, L. Lagneaux, D. Bron, 1994, Experimental hematology.

Prevention of CMV-induced myelosuppression by anti-CMV antibodies: an in vitro model.

R. Snoeck, L. Lagneaux, D. Bron, 1991, Experimental Hematology.

P. Martiat, L. Lagneaux, D. Bron, 2009, Cytotherapy.

Ex vivo myeloid differentiation of cord blood CD34+ cells: comparison of four serum-free media containing bovine or human albumin.

D. Bron, C. De Bruyn, A. Delforge, 2003, Cytotherapy.

NEUTROPENIA ASSOCIATED WITH EXCESS OF T CELL LYMPHOCYTES

D. Bron, A. Delforge, P. Stryckmans, 1981, British journal of haematology.

Excessive production of transforming growth factor-beta by bone marrow stromal cells in B-cell chronic lymphocytic leukemia inhibits growth of hematopoietic precursors and interleukin-6 production.

L. Lagneaux, D. Bron, A. Delforge, 1993, Blood.